Collegium Pharmaceutical (COLL) Other Working Capital Changes (2014 - 2026)
Collegium Pharmaceutical (COLL) recorded quarterly Other Working Capital Changes of -$167000.0 in Q1 2026, down 3240.0% quarter-over-quarter from -$5000.0 in Q4 2025, and down 101.63% on a YoY basis from $10.3 million in Q1 2025.
Collegium Pharmaceutical (COLL) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Other Working Capital Changes history runs 13 years deep, the most recent figure standing at -$167000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 101.63% year-over-year to -$167000.0; the TTM figure through Mar 2026 stood at -$10.7 million (down 144.12% YoY), while the FY2025 annual figure was -$222000.0, down 101.58% from the prior year.
- Other Working Capital Changes was -$167000.0 for Q1 2026 at Collegium Pharmaceutical, down from -$5000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $11.5 million in Q2 2024 to a low of -$21.3 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged $991058.8 across 5 years, with a median of $238000.0 in 2023.
- Biggest YoY gain for Other Working Capital Changes was 5703.39% in 2025; the steepest drop was 5016.36% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $5.6 million in 2022, then sank by 124.93% to -$1.4 million in 2023, then jumped by 239.44% to $1.9 million in 2024, then tumbled by 100.26% to -$5000.0 in 2025, then plunged by 3240.0% to -$167000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$167000.0 (Q1 2026), -$5000.0 (Q4 2025), and -$21.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -167,000.00 |
| Mar 31, 2026 | -167,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -21.34 Mn |
| Sep 30, 2025 | -21.34 Mn |
| Jun 30, 2025 | 10.85 Mn |
| Jun 30, 2025 | 10.85 Mn |
| Mar 31, 2025 | 10.27 Mn |
| Mar 31, 2025 | 10.27 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 434,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 11.51 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Mar 31, 2024 | 177,000.00 |
| Mar 31, 2024 | 177,000.00 |
| Dec 31, 2023 | -1.40 Mn |
| Dec 31, 2023 | -1.40 Mn |